Board Change

RNS Number : 8818P
Microsaic Systems plc
22 October 2021
 

22 October 2021

 

Microsaic Systems plc

("Microsaic" or the "Company")

Board Change

 

Microsaic (AIM: MSYS),   announces that, after 6 years of service, Bevan Metcalf, will be retiring as Finance Director on 17 December 2021. To ensure a smooth transition, the Company has appointed an Interim Head of Finance (non-board level), until a permanent successor is appointed. 

 

Gerry Brandon, Chairman commented:

"Bevan has been a valued colleague since 2015. He has played a valuable role in supporting the management team through his vast knowledge and experience working within industry and more recently in the development and recent turnaround of the Company. I would like to thank him for the tremendous contribution that he has made to Microsaic since his appointment as Finance Director more than 6 years ago . On behalf of our shareholders, advisors and everyone at Microsaic I would like to wish him a happy and healthy retirement."

 

 

Enquiries:


Microsaic Systems plc

Glenn Tracey, CEO - Bevan Metcalf, FD

 

+44 (0)1483 751 577

Singer Capital Markets (Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / Tom Salvesen / George Tzimas 

 


Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050



About Microsaic

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANEFALDFFFA
UK 100

Latest directors dealings